BioCurex Announces Investment Into the Company by Paulson Investment Company
31. Mai 2012 09:53 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, May 31, 2012 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that the Company today received a commitment from Paulson Investment Company Inc. to make an...
BioCurex Provides Shareholder Update on Recent Events at the Company
19. April 2012 09:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, April 19, 2012 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) is providing this update to shareholders in light of recent significant events at the company since our last...
BioCurex Wholly Owned Subsidiary, OncoPet Diagnostics, Signs Distribution Agreement With Animal Health International
28. Februar 2012 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Feb. 28, 2012 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that its wholly owned subsidiary, OncoPet™ Diagnostics, Inc., has executed a definitive...
BioCurex Updates Its Shareholders
03. Januar 2012 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Jan. 3, 2012 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) -- OncoPet Diagnostics Inc. – a fully owned subsidiary of BioCurex Inc. has developed a system to...
BioCurex Wholly Owned Subsidiary, OncoPet Diagnostics, Signs Distribution Agreement With Butler Schein Animal Health
08. Dezember 2011 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Dec. 8, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that its wholly owned subsidiary, OncoPet™ Diagnostics, Inc., has executed an agreement...
BioCurex Wholly Owned Subsidiary, OncoPet Diagnostics, Signs Distribution Agreement With Webster Veterinary
09. November 2011 09:51 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Nov. 9, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced today that its wholly owned subsidiary, OncoPet™ Diagnostics, Inc., has signed a distribution...
BioCurex RECAF(TM) Technologies Generates Attention at Recent International Scientific Meeting on Cancer Markers
27. Oktober 2011 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Oct. 27, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB: BOCX) CEO, Dr. Ricardo Moro, recently presented at the meeting of the International Society of Oncology and...
BioCurex RECAF(TM) Positioned to Solve Issues With PSA Screening
11. Oktober 2011 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Oct. 11, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that the Company believes it is positioned to solve the most pressing issues that have led to a...
BioCurex Submits Pre-Investigational Device Exemption (IDE) to the FDA for RECAF(TM)
07. Oktober 2011 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Oct. 7, 2011 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today that the Company has submitted scientific information and a request for a meeting regarding an...
Oncology Journal to Publish RECAF(TM) Test Results Showing Very High Sensitivity in Detection of Early Stages of Breast Cancer
04. Oktober 2011 08:30 ET
|
BioCurex, Inc.
RICHMOND, British Columbia, Oct. 4, 2011 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that its article entitled: "Increased AFP-Receptor (RECAF™) Values in the Serum of...